Results 151 to 160 of about 9,672 (236)

Exploring stationary phase morphologies as pathways to greener and faster LC for analyzing sofosbuvir and ledipasvir. [PDF]

Sci Rep
Ibrahim AE, Alamir SG, Salman BI, El Deeb S, Al-Harrasi A.   +4 more
europepmc   +1 more source

Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs

, 2019
Phillip O. Coffin, Glenn‐Milo Santos, Emily Behar, Jaclyn Hern, John E. Walker, Tim Matheson, Elizabeth N. Kinnard, Janelle Silvis, Eric Vittinghoff, Rena K. Fox, Kimberley Page   +10 more
openalex   +2 more sources

An eco-friendly chemometrics assisted UV spectrophotometric method for simultaneous determination of sofosbuvir, simeprevir and ledipasvir in pharmaceuticals. [PDF]

BMC Chem
Alshehri A, Alqahtani A, Alsayari A, Almrasy AA.   +3 more
europepmc   +1 more source

ENHANCEMENT SPECTRAL RESOLUTION FOR THE PREDICTION AMOUNT OF SOFOSBUVIR AND LEDIPASVIR USING LEAST SQUARES SUPPORT VECTOR MACHINE AND ARTIFICIAL NEURAL NETWORKS IN PHARMACEUTICAL FORMULATION [PDF]

, 2019
Negin Safakhoo, Mahmoud Reza Sohrabi, Mahsa Khalili, Shirin Mofavvaz   +3 more
openalex   +1 more source

Generic <i>vs</i> brand forms of direct acting antivirals for hepatitis C virus treatment in Egyptian children. [PDF]

World J Hepatol
Mogahed E, Ghita H, Enayet A, Yasin N, El-Karaksy H.   +4 more
europepmc   +1 more source

Quality of life of Japanese patients with chronic hepatitis C treated with ledipasvir and sofosbuvir

, 2016
Zobair M. Younossi, Maria Stepanova, Masao Omata, Masashi Mizokami, Mercedes Walters, Sharon Hunt   +5 more
openalex   +1 more source

Outcome of Combination Therapy with Sofosbuvir and Ledipasvir for Chronic Type C Liver Disease [PDF]

, 2016
Satoru Hagiwara, Naoshi Nishida, Tomohiro Watanabe, Toshiharu Sakurai, Hiroshi Ida, Yasunori Minami, Masahiro Takita, Tomohiro Minami, Mina Iwanishi, Hirokazu Chishina, Kazuomi Ueshima, Yoriaki Komeda, Tadaaki Arizumi, Masatoshi Kudo   +13 more
openalex   +1 more source

Health Disparities in Achieving Sustained Virologic Response Among Patients With Chronic Hepatitis C: A Retrospective Single-Center Study. [PDF]

Cureus
Leach E, Rana R, Nguyen C, Reinecke J, Hall A, Velagapudi M.   +5 more
europepmc   +1 more source

Randomised clinical trial: sofosbuvir and ledipasvir in patients with transfusion‐dependent thalassaemia and HCV genotype 1 or 4 infection [PDF]

, 2017
A. Mangia, Roberto Sarli, Rita Gamberini, Antonio Piga, Giovanni Cenderello, Valeria Piazzolla, Rosanna Santoro, Vincenzo Caruso, A Quarta, R. Ganga, Massimiliano Copetti, G. Forni   +11 more
openalex   +1 more source

Long-Term Outcomes of Ledipasvir/Sofosbuvir Treatment in Hepatitis C: Viral Suppression, Hepatocellular Carcinoma, and Mortality in Mongolia. [PDF]

Viruses
Byambasuren A, Gyarvuulkhasuren B, Erdenebat B, Nyamdavaa K, Baatarkhuu O.   +4 more
europepmc   +1 more source